RIELTOS Trademark

Trademark Overview

On Tuesday, April 12, 2016, a trademark application was filed for RIELTOS with the United States Patent and Trademark Office. The USPTO has given the RIELTOS trademark a serial number of 86972633. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 21, 2019. This trademark is owned by Loxo Oncology, Inc.. The RIELTOS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
rieltos

General Information

Serial Number86972633
Word MarkRIELTOS
Filing DateTuesday, April 12, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLoxo Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStamford, CT 06901
Party NameLoxo Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStamford, CT 06901

Trademark Events

Event DateEvent Description
Monday, October 21, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, August 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2019EXTENSION 4 GRANTED
Wednesday, February 27, 2019EXTENSION 4 FILED
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Saturday, September 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 13, 2018EXTENSION 3 GRANTED
Thursday, September 13, 2018EXTENSION 3 FILED
Thursday, September 13, 2018TEAS EXTENSION RECEIVED
Friday, February 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2018EXTENSION 2 GRANTED
Wednesday, February 7, 2018EXTENSION 2 FILED
Wednesday, February 7, 2018TEAS EXTENSION RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017EXTENSION 1 GRANTED
Tuesday, June 13, 2017EXTENSION 1 FILED
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 12, 2016ASSIGNED TO LIE
Wednesday, November 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 7, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2016ASSIGNED TO LIE
Monday, October 24, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 28, 2016NON-FINAL ACTION E-MAILED
Thursday, July 28, 2016NON-FINAL ACTION WRITTEN
Wednesday, July 27, 2016ASSIGNED TO EXAMINER
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 15, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

rieltos disease immunologic based autoimmune pharmaceutical cancer preparations treatment line full